Skip to main navigation Skip to search Skip to main content

Legomedicine - a versatile chemo-enzymatic approach for the preparation of targeted dual-labeled llama antibody-nanoparticle conjugates

  • S.A.M. van Lith
  • , S.M.J. van Duijnhoven
  • , A.C. Navis
  • , W.P.J. Leenders
  • , E. Dolk
  • , J.W.H. Wennink
  • , C.F. Nostrum, van
  • , J.C.M. van Hest

    Research output: Contribution to journal › Article › Academic › peer-review

    402 Downloads (Pure)

    Abstract

    Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu+-independent strain-promoted alkyne-azide cycloadition (SPAAC) reaction. Using this approach, tail-to-tail bispecific VHHs and VHH-targeted nanoparticles are generated without affecting VHH functionality. Furthermore, this approach allows the bioconjugation of multiple moieties to VHHs for simple and convenient production of VHH-based theranostics.

    Original languageEnglish
    Pages (from-to)539-548
    Number of pages10
    JournalBioconjugate Chemistry
    Volume28
    Issue number2
    DOIs
    Publication statusPublished - 15 Feb 2017

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Legomedicine - a versatile chemo-enzymatic approach for the preparation of targeted dual-labeled llama antibody-nanoparticle conjugates'. Together they form a unique fingerprint.

    Cite this